[Federal Register Volume 81, Number 135 (Thursday, July 14, 2016)]
[Notices]
[Pages 45504-45505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16579]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH),
Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Times and Dates: 8:15 a.m.-5:00 p.m., Mountain Time, August 9,
2016; 8:15 a.m.-1:00 p.m., Mountain Time, August 10, 2016.
Public Comment Time and Date: 5:00 p.m.-6:00 p.m.*, Mountain Time,
August 9, 2016.
[[Page 45505]]
* Please note that the public comment period may end before the
time indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend the
public comment session at the start time listed.
Place: Residence Inn by Marriott, 635 West Broadway, Idaho Falls,
Idaho 83402; Phone: (208) 542-0000; Fax: (208) 542-0021.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people. The public is
also welcome to listen to the meeting by joining the teleconference at
USA toll-free, dial-in number, 1-866-659-0537 and the pass code is
9933701.
Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=M3QDP7&role=attend&pw=ABRWH; Meeting ID: M3QDP; Entry Code:
ABRWH.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and will expire on September 30,
2017.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters for Discussion: The agenda for the Advisory Board meeting
includes: NIOSH Program Update; Department of Labor Program Update;
Department of Energy Program Update; Report by the Dose Reconstruction
Review Methods Work Group; Dose Reconstruction Report to the Secretary;
SEC Petitions Update; Site Profile review for: Pinellas Plant
(Clearwater, Florida), and United Nuclear Co. (Hematite, Missouri); SEC
petitions for: Area IV of Santa Susana Field Laboratory (1965; Ventura
County, California), Argonne National Laboratory West (1951-1979;
Scoville, Idaho), Blockson Chemical Company (1960-1991; Joliet,
Illinois), Idaho National Laboratory (1949-1970; Scoville, Idaho),
Savannah River Site (1973-2007; Aiken, South Carolina), and
Westinghouse Electric Co. (1960-2011; Bloomfield, New Jersey); and a
Board Work Session.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted to the contact person below well in advance of the meeting.
Any written comments received will be provided at the meeting in
accordance with the redaction policy provided below.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her personal
information, no attempt will be made to redact the name; however, NIOSH
will redact other personally identifiable information, such as contact
information, social security numbers, case numbers, etc., of the
commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the Federal Advisory Committee Act and
if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a living
third party, that information will be reviewed by the NIOSH FOIA
coordinator, and upon determination, if deemed appropriate, such
information will be redacted, unless the disclosure is made by the
third party's authorized representative under the Energy Employees
Occupational Illness Compensation Program Act (EEOICPA) program.
(4) In general, information concerning a deceased third party may
be disclosed; however, such information will be redacted if (a) the
disclosure is made by an individual other than the survivor claimant, a
parent, spouse, or child, or the authorized representative of the
deceased third party; (b) if it is unclear whether the third party is
living or deceased; or (c) the information is unrelated or irrelevant
to the purpose of the disclosure.
The Board will take reasonable steps to ensure that individuals
making public comment are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include: (a)
A statement read at the start of each public comment period stating
that transcripts will be posted and names of speakers will not be
redacted; (b) A printed copy of the statement mentioned in (a) above
will be displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in the
Federal Register Notice that announces Board and Subcommittee meetings.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta,
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO,
email: [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-16579 Filed 7-13-16; 8:45 am]
BILLING CODE 4163-18-P